Dr Ian Hudson is to step down from the helm of the MHRA in September 2019.

Breaking news: MHRA CEO to step down

Dr Ian Hudson, Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), has announced he is to leave his role in September...

Celebrating success: Pf Award Winners Club 2018

The third Pf Award Winners Club brought together winners past and present to commemorate the accomplishments that embody true sales excellence. On 27 September, an...
NICE collaborates with the Canadian Agency for Drugs and Technology in Health

Nick Bruce joins MAP Biopharma Limited to enhance market access capabilities

MAP BioPharma enhances market access capabilities by hiring the Director of Value Access and Policy at Amgen UK- Nick Bruce joins MAP Biopharma Limited.   Nick...
Group around table.

Tom Heyman joins International Biomedical Research Alliance board

The International Biomedical Research Alliance, a non-profit organisation which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program,...
Pf Awards logo

Pf Awards: Looking for the brightest talent in pharmaceutical sales and medical devices

Pf Awards, the UK’s premier pharmaceutical sales and medical device awards, are open for entries. Pf Awards are looking for the brightest talent working...
Kate Lancaster is the new RCOG Chief Executive

Kate Lancaster will be the new RCOG Chief Executive

Kate Lancaster, the Director of Strategy at East and North Hertfordshire NHS Trust will be the new RCOG Chief Executive.  The Royal College of Obstetricians...
Farxiga reduced the relative risk of MACE by 16% in certain patients

How to get a pay rise

You deserve to be rewarded for a job well done, but what’s the best way to approach the subject? If you’ve been putting in the...

I love my job because…Pf Award Winner Priyanka Trehan

Priyanka Trehan, Area Health Lead, MSD North West London, joint winner of the Account Project Pf Award 2018. …Since February of this year I have...
Jason McKenna, new CEO of STEM Healthcare.

Jason McKenna named CEO of STEM Healthcare

Global benchmarking company STEM Healthcare (STEM) has appointed Jason McKenna to the post of CEO. McKenna has been with STEM since 2010 and has held...

Ashfield Healthcare Communications appoints new Global Commercial Director

Ashfield, part of UDG Healthcare, has appointed Ben Beckley as Global Commercial Director of Ashfield Healthcare Communications. He will be based in Boston, USA. Beckley...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...